BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4186794)

  • 21. [Our experiences in the inhibition of undesired lactation using Ovosiston].
    Kosowski I; Iliew D
    Zentralbl Gynakol; 1972 Aug; 94(34):1134-6. PubMed ID: 4116879
    [No Abstract]   [Full Text] [Related]  

  • 22. Rate of secretion of corticosteroids in hamadryas baboons under normal conditions and following lengthy administration of chlormadinone acetate and mestranol.
    Goncharov NP
    Acta Endocrinol Suppl (Copenh); 1972; 166():428-32. PubMed ID: 4116113
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of changes in erythrocyte and resin tests induced by the use of Femigen-forte and Femifen (Polfa) preparations as contraceptives].
    Pisarek-Miedzińska D; Czech W; Firek A
    Ginekol Pol; 1974 Jan; 45(1):57-60. PubMed ID: 4131322
    [No Abstract]   [Full Text] [Related]  

  • 24. [Porphyria cutanea tarda caused by long-term use of femigen].
    Chowaniec O; Wierzbieta J
    Przegl Dermatol; 1980; 67(3):349-52. PubMed ID: 6159665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sequenz-Ovosiston as a contraceptive agent].
    Zwahr C
    Zentralbl Gynakol; 1972 Dec; 94(49):1722-5. PubMed ID: 4119508
    [No Abstract]   [Full Text] [Related]  

  • 26. [Management and evolution of endometrial hyperplasia using small doses of progestational hormones].
    Calderón JJ; García G; Maqueo M
    Ginecol Obstet Mex; 1969 Mar; 25(149):311-7. PubMed ID: 4181037
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)].
    Krause W; Böhm W; Müller W
    Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218
    [No Abstract]   [Full Text] [Related]  

  • 28. [Indications for the treatment with sequence preparations].
    Breckwoldt M; Bettendorf G
    Zentralbl Gynakol; 1969 Aug; 91(35):1147-50. PubMed ID: 4189508
    [No Abstract]   [Full Text] [Related]  

  • 29. [Early tubal abortion during oral contraception].
    Köpernik H; Timmel H
    Zentralbl Gynakol; 1972 Sep; 94(38):1248-52. PubMed ID: 4118175
    [No Abstract]   [Full Text] [Related]  

  • 30. CORRELATION BETWEEN THE STATE OF GROWTH OF THE HUMAN ENDOMETRIUM AND ITS RESPONSE TO A SYNTHETIC PROGESTAGEN (CHLORMADINONE).
    RUDEL HW; MAQUEO M; MARTINEZ-MANAUTOU J
    J Reprod Fertil; 1964 Dec; 8():305-9. PubMed ID: 14248589
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serum immunoglobulins and C-reactive protein following oral administration of ovulation inhibitors].
    Gay S; Seidenschnur G; Geiler G
    Dtsch Gesundheitsw; 1972 Jan; 27(1):32-4. PubMed ID: 4111064
    [No Abstract]   [Full Text] [Related]  

  • 32. [Handling of the menopausal patient].
    Gonzalez Gutierrez JT
    Ginecol Obstet Mex; 1967 Oct; 22(132):1371-80. PubMed ID: 4186427
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparative study of the estrogenic potential of two synthetic estrogens (mestranol and ethinylestradiol).
    Teter J; Stupnicki R
    Acta Cytol; 1971; 15(2):167-70. PubMed ID: 5282948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimpanzee endometrium and sexual swelling during menstrual cycle or hormone administration.
    Graham CE
    Folia Primatol (Basel); 1973; 19(6):458-68. PubMed ID: 4129786
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasma protein changes in post-menopausal women receiving mestranol-norethisterone hormone replacement therapy.
    Burnett D; Moore B; Williams JG; Studd JW; Bradwell AR
    Postgrad Med J; 1976; 52 Suppl 6():48-51. PubMed ID: 981119
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of chlormadinone and chlormadinone with mestranol on the liver function].
    Marcinkowski Z
    Ginekol Pol; 1978 Jun; 49(6):525-30. PubMed ID: 80353
    [No Abstract]   [Full Text] [Related]  

  • 37. [Behavior of serum copper and iron under the influence of the ovulation inhibitor Ovosiston].
    Methfessel HD; Mlytz H; Methfessel G; Löffler F
    Z Gesamte Inn Med; 1969 Oct; 24(19):659-61. PubMed ID: 4188438
    [No Abstract]   [Full Text] [Related]  

  • 38. [Trial treatment of menopause disorders by the sequential method].
    Gaudefroy M
    Rev Fr Gynecol Obstet; 1970 Oct; 65(10):591-602. PubMed ID: 4098226
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sequential therapy in premenopausal and menopausal syndromes].
    Delacroix P
    Rev Fr Gynecol Obstet; 1968 Oct; 63(10):559-64. PubMed ID: 4194277
    [No Abstract]   [Full Text] [Related]  

  • 40. THE USE OF CHLORMADINONE IN GYNECOLOGICAL PRACTICE.
    CHARLES D; LORAINE JA; BELL ET; HARKNESS RA
    Am J Obstet Gynecol; 1964 Oct; 90():364-9. PubMed ID: 14212793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.